Total Payments
$7,939
2024 Payments
$1,968
Companies
23
Transactions
274
Medicare Patients
2,910
Medicare Billing
$218,700
Payment Breakdown by Category
Food & Beverage$5,812 (73.2%)
Consulting$1,650 (20.8%)
Education$476.49 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,812 | 266 | 73.2% |
| Consulting Fee | $1,650 | 1 | 20.8% |
| Education | $476.49 | 7 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,840 | 12 | $0 (2023) |
| ABBVIE INC. | $1,234 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $1,213 | 37 | $0 (2024) |
| GENZYME CORPORATION | $533.43 | 17 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $430.92 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $371.98 | 14 | $0 (2024) |
| Lilly USA, LLC | $329.29 | 16 | $0 (2024) |
| Dermavant Sciences, Inc. | $232.43 | 13 | $0 (2024) |
| PFIZER INC. | $214.47 | 12 | $0 (2024) |
| LEO Pharma Inc. | $203.29 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,968 | 89 | Janssen Biotech, Inc. ($376.17) |
| 2023 | $3,973 | 104 | Novartis Pharmaceuticals Corporation ($1,720) |
| 2022 | $1,648 | 67 | ABBVIE INC. ($436.96) |
| 2021 | $240.19 | 12 | AbbVie Inc. ($71.40) |
| 2020 | $69.95 | 1 | Janssen Biotech, Inc. ($69.95) |
| 2019 | $39.81 | 1 | AbbVie, Inc. ($39.81) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Immunology | ||||||
| 12/17/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $30.38 | General |
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.14 | General |
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 11/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Biosimilars | ||||||
| 10/28/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: DERMATOLOGY | ||||||
| 10/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Inflammation & Immunology | ||||||
| 09/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $44.14 | General |
| 09/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Inflammation & Immunology | ||||||
| 09/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: DERMATOLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Dermatology | ||||||
| 08/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Dermatology | ||||||
| 08/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $2.09 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 719 | 1,191 | $164,653 | $54,528 |
| 2022 | 10 | 557 | 913 | $128,315 | $44,712 |
| 2021 | 10 | 670 | 934 | $181,992 | $46,898 |
| 2020 | 12 | 964 | 1,359 | $318,397 | $72,562 |
Total Patients
2,910
Total Services
4,397
Medicare Billing
$218,700
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 231 | $43,832 | $15,461 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 110 | $29,425 | $9,763 | 33.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 88 | 102 | $22,092 | $7,415 | 33.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 63 | 88 | $21,470 | $6,886 | 32.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 114 | 155 | $22,787 | $6,691 | 29.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 79 | 387 | $5,955 | $1,977 | 33.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 46 | $5,528 | $1,889 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,395 | $1,769 | 27.7% |
| 10040 | Acne surgery | Office | 2023 | 11 | 12 | $2,988 | $1,163 | 38.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 18 | 23 | $2,487 | $970.92 | 39.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,694 | $544.56 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 113 | $21,922 | $11,046 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 123 | $19,311 | $8,260 | 42.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 74 | 86 | $18,232 | $6,007 | 32.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 54 | 66 | $16,632 | $5,844 | 35.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 96 | 124 | $22,692 | $5,023 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $9,282 | $2,877 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,300 | $2,407 | 38.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 59 | 312 | $9,984 | $1,713 | 17.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 13 | 19 | $2,280 | $844.31 | 37.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $1,680 | $691.04 | 41.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 164 | $48,141 | $14,325 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 178 | 193 | $39,779 | $11,976 | 30.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 68 | 72 | $22,146 | $5,423 | 24.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 105 | 119 | $27,954 | $4,893 | 17.5% |
About Dr. Emily Keimig, M.D
Dr. Emily Keimig, M.D is a Dermatology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104035203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Keimig, M.D has received a total of $7,939 in payments from pharmaceutical and medical device companies, with $1,968 received in 2024. These payments were reported across 274 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,812).
As a Medicare-enrolled provider, Keimig has provided services to 2,910 Medicare beneficiaries, totaling 4,397 services with total Medicare billing of $218,700. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Detroit, MI
- Active Since 05/22/2007
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1104035203
Products in Payments
- COSENTYX (Drug) $1,720
- TREMFYA (Drug) $1,128
- DUPIXENT (Biological) $880.62
- SKYRIZI (Biological) $513.54
- RINVOQ (Biological) $488.03
- TALTZ (Drug) $306.09
- ILUMYA (Biological) $248.29
- VTAMA (Drug) $232.43
- ADBRY (Biological) $203.29
- OPZELURA (Drug) $195.38
- Winlevi (Drug) $161.73
- Otezla (Drug) $158.39
- EUCRISA (Drug) $113.56
- CIBINQO (Drug) $100.91
- BOTOX (Biological) $92.16
- REMICADE (Biological) $85.25
- Sotyktu (Drug) $85.19
- Bimzelx (Biological) $84.64
- COSENTYX (Biological) $72.20
- IDACIO (Biological) $71.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Detroit
David Ozog, M.d, M.D
Dermatology — Payments: $28,730
Dermatology $28,730
Karen Heidelberg, M.d, M.D
Dermatology — Payments: $11,115
Dermatology $11,115
Dr. Richard Huggins, M.d, M.D
Dermatology — Payments: $10,683
Dermatology $10,683
Dr. Tina Pickett Baisden, Md, MD
Dermatology — Payments: $8,752
Dermatology $8,752
Dr. Snehal Desai, M.d, M.D
Dermatology — Payments: $7,297
Dermatology $7,297
Leah Cardwell, M.d, M.D
Dermatology — Payments: $5,220
Dermatology $5,220